Interpretatie van door de patiënt gerapporteerde uitkomstgegevens
Samenvatting
- Interpretatiebenaderingen helpen zorgverleners om de mogelijke betekenis van PROM-scores te begrijpen.
- Het interpreteren van PRO-gegevens in de routinematige klinische zorg vereist het beoordelen van de klinische relevantie en het contextualiseren van scores binnen de individuele situatie en gezondheidstoestand van de patiënt. Alle aannames op basis van de scores moeten worden gecontroleerd en gevalideerd via een gericht gesprek met de patiënt
- Voor EORTC PROMs zijn drempelwaarden voor klinische betekenis (thresholds for clinical importance; TCIs), referentiewaarden en normgegevens en drempelwaarden voor interpretatie van PRO-scores (PRO score interpretation thresholds, PROSITs) ontwikkeld.
- TCIs helpen om symptoom- en functioneringsgebieden die verdere aandacht vereisen snel te identificeren.
- Referentiewaarden en normgegevens kunnen worden gebruikt om de scores van een patiënt te vergelijken met die van vergelijkbare patiëntengroepen of de algemene bevolking.
- PROSITs kunnen de identificatie van verslechtering of verbetering in de loop van de tijd ondersteunen als er meerdere meetpunten (monitoring) beschikbaar zijn.
Angelos P. Kassianos (Ed.). (2022). Handbook of Quality of Life in Cancer. Springer. https://doi.org/10.1007/978-3-030-84702-9
Desomer, A., Van den Heede, K.,Triemstra, M., Paget, J., De Boer, D., Kohn, L., Cleemput, I. (2018). Use of patient-reported outcome and experience measures in patient care and policy – Short report. Health Services Research (HSR): Belgian Health Care Knowledge Centre (KCE). KCE Reports 303Cs. D/2018/10.273/39.
Giesinger, J. M., Aaronson, N. K [Neil K.], Arraras, J. I., Efficace, F., Groenvold, M [Mogens], Kieffer, J. M., Loth, F. L., Petersen, M. A [Morten Aa], Ramage, J., Tomaszewski, K. A [Krzysztof A.], Young, T., & Holzner, B [Bernhard] (2018). A cross-cultural convergent parallel mixed methods study of what makes a cancer-related symptom or functional health problem clinically important. Psychooncology, 27(2), 548–555. https://doi.org/10.1002/pon.4548
Giesinger, J. M., Loth, F. L. C., Aaronson, N. K [Neil K.], Arraras, J. I., Caocci, G., Efficace, F., Groenvold, M [Mogens], van Leeuwen, M., Petersen, M. A [Morten Aa], Ramage, J., Tomaszewski, K. A [Krzysztof A.], Young, T., & Holzner, B [Bernhard] (2020). Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research. Journal of Clinical Epidemiology, 118, 1–8. https://doi.org/10.1016/j.jclinepi.2019.10.003
Giesinger, J. M., Lehmann, J. (2022). The European Organisation for Research and Treatment of Cancer (EORTC) Measurement System. In Angelos P. Kassianos (Ed.), Handbook of Quality of Life in Cancer (pp. 61–77). Springer. (Original work published 2022)
King, M. T [M. T.] (1996). The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 5(6), 555–567. https://doi.org/10.1007/BF00439229
King, M. T [Madeleine T.] (2011). A point of minimal important difference (MID): A critique of terminology and methods. Expert Review of Pharmacoeconomics & Outcomes Research, 11(2), 171–184. https://doi.org/10.1586/erp.11.9
Musoro, J. Z., Coens, C., Sprangers, M. A. G., Brandberg, Y., Groenvold, M., Flechtner, H. H., Cocks, K., Velikova, G., Dirven, L., Greimel, E., Singer, S., Pogoda, K., Gamper, E. M., Sodergren, S. C., Eggermont, A., Koller, M., Reijneveld, J. C., Taphoorn, M. J. B., King, M. T., Bottomley, A., … EORTC Melanoma, Breast, Head and Neck, Genito-urinary, Gynecological, Gastro-intestinal, Brain, Lung and Quality of Life Groups (2023). Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types. European journal of cancer (Oxford, England : 1990), 188, 171–182. https://doi.org/10.1016/j.ejca.2023.04.027
Nolte, S., Liegl, G., Petersen, M. A [M. A.], Aaronson, N. K [N. K.], Costantini, A., Fayers, P. M., Groenvold, M [M.], Holzner, B [B.], Johnson, C. D., Kemmler, G., Tomaszewski, K. A [K. A.], Waldmann, A., Young, T. E., & Rose, M. (2019). General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States. European Journal of Cancer (Oxford, England : 1990), 107, 153–163. https://doi.org/10.1016/j.ejca.2018.11.024
Porter, I., Gonçalves-Bradley, D., Ricci-Cabello, I., Gibbons, C., Gangannagaripalli, J., Fitzpatrick, R., Black, N., Greenhalgh, J., & Valderas, J. M. (2016). Framework and guidance for implementing patient-reported outcomes in clinical practice: Evidence, challenges and opportunities. Journal of Comparative Effectiveness Research, 5(5), 507–519. https://doi.org/10.2217/cer-2015-0014
Scott et al. (2008). EORTC QLQ-C30 Reference Values. https://www.eortc.org/app/uploads/sites/2/2018/02/reference_values_manual2008.pdf
Sztankay, M., Wintner, L. M., Roggendorf, S., Nordhausen, T., Dirven, L., Taphoorn, M. J. B., Verdonck-de Leeuw, I. M., Velikova, G., Bottomley, A., Kulis, D., Kachel, T., Schmidt, H., & on behalf of the EORTC Quality of Life Group (2022). Developing an e-learning course on the use of PRO measures in oncological practice: health care professionals' preferences for learning content and methods. Supportive Care in Cancer, 30(3), 2555–2567. https://doi.org/10.1007/s00520-021-06676-x
Wintner, L., Sztankay, M., Giesinger, J. M., Aaronson, N., Bottomley, A., Velikova, G., Verdonck de Leeuw, I., van de Poll-Franse, L., Groenvold, M., Petersen, M.A., Holzner, B. (2016). EORTC Quality of Life Group Manual for the use of EORTC measures in daily clinical practice. https://www.eortc.org/app/uploads/sites/2/2018/02/EORTC_QLQ_Clinical_Practice_User_Manual-1.0.pdf
| Auteur(s) (jaar) | Naam (link naar document) | Taal |
|---|---|---|
| EORTC (2008) | Reference Values Manual (link) | Engels |
| EORTC (2001) | Scoring Manual (link) | Engels |
| EORTC (-) | EORTC QLG Interpretation Guideline de ontwikkeling is nog gaande (link) |
Engels |
| EORTC (-) | Reference Value Database de ontwikkeling is nog gaande (link) |
Engels |